(Q42546433)

2 November 2017

The acute and long-term effect of olanzapine compared with placebo and haloperidol on serum prolactin concentrations (English)

1 reference

2 November 2017

1 reference

1 reference

A M Crawford

1

1 reference

2 November 2017

C M Beasley

series ordinal

2

1 reference

2 November 2017

G D Tollefson

series ordinal

3

1 reference

2 November 2017

language of work or name

English

0 references

publication date

1 July 1997

1 reference

2 November 2017

Schizophrenia Research

1 reference

2 November 2017

26

1 reference

2 November 2017

41-54

1 reference

2 November 2017

1

1 reference

Differential effects of classical and newer antipsychotics on the hypermotility induced by two dose levels of D-amphetamine

2 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900036-4

7 January 2021

A rating scale for drug-induced akathisia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900036-4

7 January 2021

Olanzapine versus placebo and haloperidol: acute phase results of the North American double-blind olanzapine trial

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900036-4

7 January 2021

Olanzapine versus placebo: results of a double-blind, fixed-dose olanzapine trial

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900036-4

7 January 2021

Radioreceptor binding profile of the atypical antipsychotic olanzapine.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900036-4

7 January 2021

Neurochemical evidence for antagonism by olanzapine of dopamine, serotonin, alpha 1-adrenergic and muscarinic receptors in vivo in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900036-4

7 January 2021

The olfactory tubercle as a site of action of neuroleptics with an atypical profile in the paw test: effect of risperidone, prothipendyl, ORG 5222, sertindole and olanzapine

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900036-4

7 January 2021

Clozapine: plasma levels and prolactin response

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900036-4

7 January 2021

Effects of the menstrual cycle on dependent variables in mood disorder research.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900036-4

7 January 2021

Pulsatile secretion of prolactin and luteinizing hormone and their synchronous relationship during the human menstrual cycle

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900036-4

7 January 2021

The Mechanism of Action of Novel Antipsychotic Drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900036-4

7 January 2021

Effect of clozapine on human serum prolactin levels

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900036-4

7 January 2021

Effects of olanzapine on regional C-Fos expression in rat forebrain.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900036-4

7 January 2021

Electrophysiological effects of olanzapine, a novel atypical antipsychotic, on A9 and A10 dopamine neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900036-4

7 January 2021

Olanzapine, a novel atypical antipsychotic, reverses d-amphetamine-induced inhibition of midbrain dopamine cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2897%2900036-4

7 January 2021

10.1016/S0920-9964(97)00036-4

Identifiers

DOI

1 reference

2 November 2017

1 reference